Trademark: 87143137
Status Date
Friday, January 26, 2024
Registration Number
5239908
Registration Date
Tuesday, July 11, 2017
Filing Date
Thursday, August 18, 2016
Published for Opposition
Tuesday, March 7, 2017
Cancellation Date
Friday, January 26, 2024
5 Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Jan 26, 2024
Cancelled Sec. 8 (6-Yr)
Jul 11, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 11, 2017
Registered-Principal Register
Jun 2, 2017
1(B) Basis Deleted; Proceed To Registration
May 2, 2017
Notice Of Allowance Cancelled
May 19, 2017
Case Assigned To Intent To Use Paralegal
May 2, 2017
Teas Post Publication Amendment Received
May 2, 2017
Noa E-Mailed - Sou Required From Applicant
Mar 7, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2017
Published For Opposition
Feb 15, 2017
Notification Of Notice Of Publication E-Mailed
Feb 2, 2017
Law Office Publication Review Completed
Jan 18, 2017
Approved For Pub - Principal Register
Jan 6, 2017
Teas/Email Correspondence Entered
Jan 6, 2017
Correspondence Received In Law Office
Dec 15, 2016
Assigned To Lie
Dec 1, 2016
Teas Response To Suspension Inquiry Received
Nov 21, 2016
Notification Of Letter Of Suspension E-Mailed
Nov 21, 2016
Letter Of Suspension E-Mailed
Nov 21, 2016
Suspension Letter Written
Nov 16, 2016
Assigned To Examiner
Aug 23, 2016
New Application Office Supplied Data Entered
Aug 22, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
